TROIA, ROSSELLA
 Distribuzione geografica
Continente #
NA - Nord America 2.869
EU - Europa 1.156
AS - Asia 790
SA - Sud America 82
OC - Oceania 22
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.932
Nazione #
US - Stati Uniti d'America 2.768
IT - Italia 343
CN - Cina 322
FR - Francia 157
IN - India 123
JP - Giappone 122
GB - Regno Unito 94
SE - Svezia 73
ES - Italia 72
IE - Irlanda 67
CA - Canada 63
DE - Germania 61
NL - Olanda 48
UA - Ucraina 44
TR - Turchia 42
SG - Singapore 31
CH - Svizzera 30
BR - Brasile 29
PL - Polonia 27
GR - Grecia 25
MX - Messico 24
AT - Austria 23
IL - Israele 23
VN - Vietnam 23
HK - Hong Kong 22
PT - Portogallo 16
TW - Taiwan 16
AU - Australia 15
CO - Colombia 15
BE - Belgio 14
NO - Norvegia 13
SA - Arabia Saudita 13
FI - Finlandia 12
KR - Corea 12
AR - Argentina 11
RU - Federazione Russa 11
CL - Cile 10
KW - Kuwait 9
TH - Thailandia 8
UY - Uruguay 8
HU - Ungheria 7
NZ - Nuova Zelanda 6
PE - Perù 6
TT - Trinidad e Tobago 6
DK - Danimarca 5
QA - Qatar 5
AM - Armenia 4
EU - Europa 4
KY - Cayman, isole 4
ZA - Sudafrica 4
CZ - Repubblica Ceca 3
EE - Estonia 3
PH - Filippine 3
RO - Romania 3
SI - Slovenia 3
UZ - Uzbekistan 3
CR - Costa Rica 2
EG - Egitto 2
ID - Indonesia 2
IS - Islanda 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
EC - Ecuador 1
JM - Giamaica 1
LB - Libano 1
NG - Nigeria 1
NP - Nepal 1
PF - Polinesia Francese 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
SN - Senegal 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.932
Città #
Houston 361
Redwood City 132
Fairfield 121
Florence 110
Cambridge 103
Chandler 83
Ashburn 71
Dublin 62
Beijing 53
Torino 44
Tokyo 41
Seattle 40
Wilmington 40
Woodbridge 40
Ann Arbor 39
Portland 38
Los Angeles 36
Shanghai 36
Paris 33
Minneapolis 30
New York 29
Baltimore 27
Hangzhou 24
Rochester 24
Nanjing 23
Nyköping 23
Guangzhou 22
Turin 22
Ottawa 21
Chicago 20
Medford 19
Norwalk 19
London 18
Singapore 18
Athens 17
Boston 17
Duncan 17
Hyderabad 17
Philadelphia 17
Toronto 17
Princeton 16
San Francisco 16
Columbus 15
Indianapolis 15
Jacksonville 14
Loma Linda 14
Madrid 14
San Diego 14
Breda 13
Charlotte 13
Pittsburgh 13
Providence 13
St Louis 13
Dong Ket 12
Honolulu 12
Pisa 12
Toledo 12
Vienna 12
Flushing 11
Grand Rapids 11
Greenville 11
Scarsdale 11
Chengdu 10
Louisville 10
Newbury Park 10
Santiago 10
Shenyang 10
Aurora 9
Dearborn 9
Miami 9
Notre Dame 9
Omaha 9
Orlando 9
San Francesco 9
Seoul 9
Vedène 9
Warsaw 9
Amsterdam 8
Atlanta 8
Bengaluru 8
Bogotá 8
Clemmons 8
Durham 8
Kansas City 8
Montevideo 8
Mumbai 8
Owensboro 8
Salt Lake City 8
Temple 8
Wappingers Falls 8
Washington 8
Wuhan 8
Arlington 7
Campi Bisenzio 7
Changsha 7
Dallas 7
Freiburg im Breisgau 7
Kunming 7
La Jolla 7
Lima 7
Totale 2.527
Nome #
Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study 2.395
Pharmacokinetic drug evaluation of ixazomib citrate for the treatment of multiple myeloma 755
Melphalan hydrochloride for the treatment of multiple myeloma 654
Pharmacokinetic evaluation of pomalidomide for the treatment of myeloma 193
Salvage therapy in first relapse: a retrospective study in a large patient population with multiple myeloma 180
Minimal residual disease by flow cytometry and allelic-specific oligonucleotide real-time quantitative polymerase chain reaction in patients with myeloma receiving lenalidomide maintenance: A pooled analysis 165
Autologous transplant vs oral chemotherapy and lenalidomide in newly diagnosed young myeloma patients: A pooled analysis 156
Minimal residual disease assessment by multiparameter flow cytometry in transplant-eligible myeloma in the EMN02/HOVON 95 MM trial 130
Promises and pitfalls in the use of PD-1/PD-L1 inhibitors in multiple myeloma 108
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma 93
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma 92
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study 58
Monoclonal antibodies currently in Phase II and III trials for multiple myeloma 53
Totale 5.032
Categoria #
all - tutte 8.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201966 0 0 0 0 0 0 0 0 0 0 49 17
2019/2020681 17 16 22 30 27 16 57 168 192 60 49 27
2020/2021896 18 29 101 60 72 101 83 100 94 78 73 87
2021/20221.113 67 70 75 92 98 55 176 92 65 80 118 125
2022/20231.089 66 87 81 83 75 113 91 92 110 103 103 85
2023/2024973 81 105 89 100 92 101 114 121 30 89 51 0
Totale 5.032